Ann G. Zauber

Memorial Sloan-Kettering Cancer Center, New York

Dr. Ann Zauber is Member and Attending Biostatistician in the Department of Epidemiology and Biostatistics at Memorial Sloan-Kettering Cancer Center in New York with a primary focus on colorectal cancer prevention.  She has a Ph.D. in biostatistics from the Johns Hopkins University Bloomberg School of Public Health and completed a post doctoral fellowship in Epidemiology at the University of Pittsburgh Graduate School of Public Health. Her research is focused on ways to reduce the burden of colorectal cancer through colorectal cancer screening; colonoscopy surveillance for adenoma patients; and microsimulation modeling of colorectal cancer risk factors, screening and surveillance and cancer treatment. The modeling work is part of the Cancer Intervention and Surveillance Modeling Network (CISNET) of NCI and is designed to inform health policy decisions. Our models have been used by the US Preventive Services Task Force and the Centers for Medicare and Medicaid Services in their decisions in health policy.  She was the biostatistician for the National Polyp Study which assessed the timing of colonoscopy surveillance intervals for adenoma patients following initial polypectomy and recently demonstrated that removing adenomas reduced colorectal cancer mortality by more than fifty percent over 20 years compared to the general population.